Sequencing and functional characterization of SCARB1 variants in subjects with extreme HDL cholesterol levels.

• SCARB1 was sequenced in 96 extreme-high-density lipoprotein cholesterol (HDL-C) subjects; 25 variants identified. • Novel c.-177G>T promoter and missense p.(Thr118Ser) were described. • p.(Thr118Ser) and p.(Thr378Met) co-segregate with high HDL-C. • p.(Thr378Met) variant impairs SR-B1–mediated HDL...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Clinical Lipidology Vol. 20; no. 2; pp. 389 - 402
Autores principales: Gracia-Rubio, Irene, Benito-Vicente, Asier, Lamiquiz-Moneo, Itziar, Bea, Ana María, Marco-Benedí, Victoria, Cabrera-Antón, Endika, Martín, César, Civeira, Fernando, Cenarro, Ana
Formato: Journal Article
Publicado: Elsevier B.V. Feb2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=191980779&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 191980779
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        19332874
        54Y0
      jtl: Journal of Clinical Lipidology
      issn: 19332874
      maglogo: N
    pubinfo:
      dt: Feb2026
      vid: 20
      iid: 2
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        191980779
        10.1016/j.jacl.2025.11.017
        191980779
      ppf: 389
      ppct: 13
      formats:
      tig:
        atl: Sequencing and functional characterization of SCARB1 variants in subjects with extreme HDL cholesterol levels.
      aug:
        au:
          Gracia-Rubio, Irene
          Benito-Vicente, Asier
          Lamiquiz-Moneo, Itziar
          Bea, Ana María
          Marco-Benedí, Victoria
          Cabrera-Antón, Endika
          Martín, César
          Civeira, Fernando
          Cenarro, Ana
        affil: Unidad Clínica y de Investigación en Lípidos y Arteriosclerosis, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza. Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain
      sug:
        subj:
          Lipoproteins, HDL Cholesterol Blood
          Sequence Analysis
          Gene Expression
          Antigens, Surface Physiology
          Receptors, Cell Surface Physiology
          Antigens, Surface Analysis
          Receptors, Cell Surface Analysis
          Human
          Lipoproteins, HDL Cholesterol Analysis
          Cardiac Patients
          Phenotype
          Biochemistry
          Anthropometry
          Bioinformatics
          Flow Cytometry
          Triglycerides
          Body Mass Index
          Coronary Arteriosclerosis Risk Factors
      ab: • SCARB1 was sequenced in 96 extreme-high-density lipoprotein cholesterol (HDL-C) subjects; 25 variants identified. • Novel c.-177G>T promoter and missense p.(Thr118Ser) were described. • p.(Thr118Ser) and p.(Thr378Met) co-segregate with high HDL-C. • p.(Thr378Met) variant impairs SR-B1–mediated HDL uptake in vitro. Rare variants in SCARB1 , which encodes the high-density lipoprotein (HDL) receptor scavenger receptor class B type 1 (SR-B1), are hypothesized to drive unexplained extreme levels of plasma HDL cholesterol (HDL-C). We sequenced and phenotypically correlated SCARB1 by analyzing individuals with extreme HDL-C levels and characterizing the functional consequences of rare identified variants. SCARB1 was Sanger-sequenced in 96 unrelated participants with extreme HDL-C levels. Clinical, biochemical, and anthropometric data were compared between groups. Bioinformatic tools were used to predict the functional impact of all detected variants. Familial analyses of predicted damaging in silico or not previously described variants was assessed, and HDL uptake was quantified by flow cytometry in HEK293 cells expressing rare SCARB1 variants showing a suggestive pattern of familial segregation. Compared with the high-HDL-C group, low-HDL-C subjects exhibited lower low-density lipoprotein cholesterol and total cholesterol but higher triglycerides, higher body mass index, and a greater frequency of atherosclerotic cardiovascular disease events. Twenty-five SCARB1 variants were identified; 4 of them, c.-177G>T, p.(Thr118Ser), c.843-982G>A and p.(Thr378Met), were predicted to be deleterious. The missense changes p.(Thr118Ser) and p.(Thr378Met) showed a suggestive pattern of segregation with high HDL-C in available pedigrees. Cells expressing p.(Thr378Met) SCARB1 variant showed a reduction in HDL uptake vs wild-type. Rare predicted damaging in silico variant in SCARB1 , p.(Thr378Met), impairs SR-B1-mediated HDL uptake and associates with high HDL-C levels, highlighting SCARB1 as a candidate gene for genetic screening in dyslipidemic patients.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N